Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38081

ANKRD28 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

CRISPR/Cas9-edited polyclonal ANKRD28 knockout HEK293T cells offer a loss-of-function model to study protein phosphatase 1 (PP1) targeting and cytoskeletal regulation. ANKRD28 serves as a regulatory subunit that directs PP1 catalytic activity to substrates at focal adhesions and the actin cytoskeleton, interacting with PPP1CA and DAPK1. This model enables detailed investigation of cell adhesion, migration, and mitotic progression, with applications in cancer biology, apoptosis signaling, and phospho-proteomic screening. The knockout population is compatible with immunofluorescence, co-immunoprecipitation, and migration assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ANKRD28

    Gene Identifier

    NCBI Gene ID 23243

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

ANKRD28 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population in which the gene encoding ankyrin repeat domain 28 (ANKRD28) has been disrupted to generate a loss-of-function model. This polyclonal knockout cell pool, generated from the widely used HEK293T host line, facilitates the study of ANKRD28-dependent processes without the use of clonal selection, thereby preserving population-level heterogeneity. The engineered disruption abolishes functional ANKRD28 expression, enabling downstream investigations into protein phosphatase 1 (PP1) targeting and cytoskeletal regulation.

HEK293T cells are human embryonic kidney epithelial cells transformed with sheared adenovirus 5 DNA and stably expressing the SV40 large T antigen. This antigen permits episomal replication of plasmids containing the SV40 origin of replication, making the line highly amenable to transient transfection, protein overexpression, and viral vector production. Their robust growth characteristics and ease of manipulation have established HEK293T as a standard host for functional genomics, signal transduction studies, and high-throughput screening applications.

ANKRD28 encodes a regulatory subunit of serine/threonine protein phosphatase 1 (PP1) that directs catalytic activity toward substrates involved in actin cytoskeleton organization, cell adhesion, and mitotic progression. Mechanistically, ANKRD28 scaffolds PPP1CA to macromolecular complexes at focal adhesions and stress fibers, where it dephosphorylates targets such as myosin light chain, cofilin, and retinoblastoma protein. Disruption of ANKRD28 leads to hyperphosphorylation of these substrates, resulting in impaired cytoskeletal dynamics, defective cell adhesion and migration, and aberrant mitotic progression. ANKRD28 also interacts with death-associated protein kinase 1 (DAPK1) to modulate apoptosis, integrating signals from the cell cycle machinery and E2F transcription factors.

Knockout of ANKRD28 in HEK293T cells provides a physiologically relevant model to dissect PP1-directed regulation within an epithelial background. Given the role of HEK293T in cell adhesion and migration studies, this knockout line enables precise examination of how ANKRD28-dependent dephosphorylation controls focal adhesion turnover, stress fiber assembly, and motility. Additionally, the expression of SV40 large T antigen may intersect with PP1/Rb pathways, offering a unique context to explore cell cycle control and transformation. The model is therefore valuable for both basic cell biology and translational oncology research.

This knockout cell pool is suitable for a range of advanced applications, including elucidation of PP1 targeting mechanisms in actin cytoskeletal remodeling, investigation of cancer cell migration and invasion via transwell and wound healing assays, and dissection of the ANKRD28?CDAPK1 complex in apoptosis through Annexin V staining and caspase activation profiling. Users may perform co-immunoprecipitation with PPP1CA to assess phosphatase complex integrity, quantify phospho-myosin light chain by Western blotting, visualize focal adhesion dynamics by immunofluorescence for vinculin, and conduct phosphoproteomic mass spectrometry to identify downstream phosphorylation events. High-content screening for PP1 modulators is also feasible. For further technical information or to request custom knockout services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)